Alain Rook is a Dermatology physician affiliated with University of Pennsylvania. OpenAlex indexes 302 publications with 17,865 citations (h-index 68); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3400 Civic Center Blvd
1-330s Perelman Center
Philadelphia, PA 191044306
Telephone
215-662-2737Registry record last updated 2 Apr 2012.
Clinical trials
- Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)
Sponsor: Abramson Cancer Center at Penn Medicine
- Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year20251 payment
- Therakos Healthcare LLCProgram year20241 payment
- Mallinckrodt Hospital Products Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38.2%Interferon gamma16.9%Actimmune100%Part D<11 patientsRetinoid11.8%Bexarotene100%Part D<11 patients+ 1 more class in this area
Dermatology
22.1%Corticosteroid22.1%Triamcinolone Acetonide60%Halobetasol Propionate40%Part D<11 patientsSensory organs
18.4%Corticosteroid18.4%Clobetasol Propionate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
10 NIH research awards on record, funded 1993–2014 per NIH RePORTER. The latest:
- CD164 as a novel biomarker for malignant CD4 T cells in cutaneous T cell lymphoma
University of Pennsylvania
FY2014$168,781R21CA178424 - CD164 as a novel biomarker for malignant CD4 T cells in cutaneous T cell lymphoma
University of Pennsylvania
FY2013$208,800R21CA178424 - Phase 1 Study of Resiquimod Gel Therapy for Cutaneous T-Cell Lymphoma
University of Pennsylvania
FY2013$196,942R01FD004092
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study
Journal of Clinical Oncology
2019 - Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin
Acta Dermato Venereologica
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania
Ravi Amaravadi, MD
University of Pennsylvania
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”